Related by context. All words. (Click for frequent words.) 74 BRCA mutation 73 BRCA2 mutation 73 BRCA2 mutations 72 mutated BRCA1 71 BRCA2 genetic mutations 70 gene BRCA2 70 BRCA2 carriers 70 BRCA2 gene 69 BRCA1 mutation 69 BRCA2 gene mutations 69 BRCA2 mutation carriers 68 APOE e4 68 BRCA1 mutations 67 BRCA mutations 67 breast cancer genes BRCA1 67 BRCA gene mutation 66 ApoE4 gene 65 genes BRCA1 65 ductal breast cancer 65 breast endometrial 65 testicular germ cell 65 ApoE4 allele 64 breast cancer gene mutation 64 BRCA1 BRCA2 64 BRCA1 mutation carriers 64 CHEK2 64 IgA deficiency 63 advanced adenoma 63 familial pancreatic cancer 63 MYH9 gene 63 Colon polyps 63 HER2 expression 63 intestinal polyps 63 Asymptomatic 63 noncarriers 63 adenomatous polyps 63 TGFBR1 * 6A 63 hormone receptor negative 63 KRAS mutations 63 hepatitis B infection 63 lung adenocarcinoma 63 atypical hyperplasia 63 chlamydial infection 63 BRCA1 gene 63 thrombophilia 63 BRCA1 gene mutation 63 endometrial cancers 63 HNSCC 62 BRCA mutation carriers 62 Squamous 62 Hurthle cell 62 advanced neoplasia 62 hereditary breast cancer 62 APOE gene 62 bladder cancers 62 APOE4 62 ADPKD 62 MLH1 62 inherited mutations 62 Li Fraumeni 62 prostate cancer CaP 62 precursor lesions 62 mutated K ras 62 Genetic variants 62 germline mutations 62 placental malaria 62 polyp recurrence 62 BRCA gene mutations 62 familial adenomatous polyposis 62 BRCA carriers 62 V Leiden 62 precancerous cervical 62 gynecologic malignancy 62 seropositivity 62 K ras mutations 62 peritoneal cancer 62 gestational hypertension 62 prostate adenocarcinoma 61 BRCA2 breast cancer 61 transferrin saturation 61 anovulatory infertility 61 recurrent metastatic 61 TCF#L# gene 61 breast uterine 61 colorectal adenoma 61 CC genotype 61 lobular breast cancer 61 ABCB1 61 ApoE4 61 malignant neoplasm 61 metastatic gastric 61 advanced adenomas 61 salpingo oophorectomy 61 operable breast cancer 61 BRAC2 61 hereditary predisposition 61 BARD1 61 endometrial hyperplasia 61 lobular carcinoma 61 invasive ductal 61 HNPCC 61 BRIP1 61 p# mutations 61 ovarian cervical 61 ovarian endometrial 61 GISTs 61 thyrotropin levels 61 apolipoprotein E4 61 ductal cancer 61 Folic acid supplements 61 HIV seropositive 61 Uterine cancer 60 CCR5 delta# 60 ε4 60 APOL1 60 MTHFR 60 bilateral oophorectomy 60 TT genotype 60 CIN2 + 60 breast pancreatic 60 gene predisposing 60 colorectal neoplasia 60 MSH2 60 MYCN amplification 60 ovarian breast 60 #q# deletion 60 elevated triglyceride levels 60 bronchogenic carcinoma 60 colon rectal 60 uterine ovarian 60 sCJD 60 abnormal Pap test 60 promoter hypermethylation 60 endometrial carcinoma 60 TP# mutation 60 shorter telomere length 60 obstructive coronary artery 60 relapsed ALL 60 gallstone disease 60 APOE ε4 60 Brain metastases 60 renal cell carcinomas 60 renal carcinoma 60 apolipoprotein E gene 60 microdeletions 60 p# mutation 60 oesophageal adenocarcinoma 60 MGUS 60 situ LCIS 60 BRCA2 60 TP# mutations 59 G#S mutation 59 clinically detectable 59 coinfection 59 chorioamnionitis 59 BRCA1 59 nonmelanoma skin cancers 59 chronic HBV 59 lobular cancer 59 oral squamous cell 59 G6PD deficiency 59 variant alleles 59 testicular tumors 59 nonmetastatic 59 cervical carcinoma 59 histological subtype 59 ductal carcinomas 59 poorer prognosis 59 basal cell nevus syndrome 59 fetal chromosomal 59 hereditary breast 59 FGFR2 gene 59 idiopathic PAH 59 precancerous polyp 59 CDH1 59 Hashimoto thyroiditis 59 neoplasias 59 endocrine therapies 59 recurrent UTI 59 Fragile X gene 59 lymph node biopsies 59 breast carcinoma 59 EGFR mutation 59 LQTS 59 ApoE gene 59 pharyngeal cancer 59 PALB2 59 BRAF V#E mutation 59 frequently benign tumor 59 lymphatic cancers 59 BCG vaccinated 59 squamous cell lung cancer 59 hypermethylated 59 chromosomal aberrations 59 gestational diabetes mellitus 59 Epstein Barr virus EBV 59 axillary lymph nodes 59 thromboembolisms 59 precancerous cervical lesions 59 nodal metastasis 59 pancreatic adenocarcinoma 59 normal karyotype 59 atrophic gastritis 59 Adjuvant chemotherapy 59 skeletal metastases 59 vaginal lesions 59 human papillomaviruses HPV 59 leiomyomas 59 papillary carcinoma 59 gastric carcinoma 59 prostate pancreatic 59 KRAS oncogene 59 CYP#C# [001] 59 albumin excretion 59 G allele 59 diffuse gastric 59 undescended testes 59 ASCUS 59 Heavy menstrual bleeding 59 bowel polyps 59 diagnosed prenatally 59 CYP#C# * 59 BRCA genes 58 HBV infection 58 cervical intraepithelial neoplasia 58 distant metastasis 58 KIF6 gene 58 oropharyngeal cancer 58 chronic hepatitis cirrhosis 58 Adenomas 58 invasive ductal breast cancer 58 Apolipoprotein E4 58 HGPIN 58 CIN3 58 genes predisposing 58 alpha1 antitrypsin deficiency 58 UGT#A# * 58 PTPN# 58 neuroblastoma tumors 58 colorectal carcinoma 58 prostate abnormalities 58 genetic variants associated 58 pilocytic astrocytomas 58 oophorectomy 58 HER2 positive cancers 58 HIV HCV coinfected 58 abnormal Pap smear 58 ovarian pancreatic 58 gastric adenocarcinoma 58 overexpress HER2 58 untreated celiac disease 58 faulty BRCA genes 58 prostate carcinoma 58 HG PIN 58 #.#ng/ml 58 inherited predisposition 58 invasive lobular 58 Genetic mutations 58 gene APOE 58 HBsAg 58 ovarian hyperstimulation 58 familial ALS 58 seronegative 58 BRCA 58 HPV genotypes 58 APOE e4 gene 58 CDKN2A 58 mutated BRAF gene 58 FGFR2 58 NNRTI resistance 58 invasive cervical cancer 58 proband 58 serum selenium 58 deCODE BreastCancer TM 58 shorter telomeres 58 chlamydial infections 58 testicular cancers 58 GPC5 58 autoimmune thyroid 58 Anaplastic 58 postmenopausal breast cancer 58 homocysteine concentrations 58 parous women 58 tuberculin skin testing 58 estrogen receptor negative 58 herpes infection 58 APOE genotype 58 anal cancers 58 discontinued Viread 58 uterine cancers 58 preeclamptic 58 bowel cancers 58 cranial irradiation 58 rs# [002] 58 serous ovarian cancer 58 Hepatitis B virus 58 SCN1A 58 BRCA gene 58 nonsmall cell lung cancer 58 Myocardial infarction 58 colorectal cancer CRC 58 basal cell carcinoma BCC 58 fibroids endometriosis 58 subclinical hyperthyroidism 58 Papillary 58 PCa 58 PTEN mutations 58 de ath 58 oncogenic HPV 58 BMPR2 58 histologic subtype 58 genetic polymorphisms 58 familial hypercholesterolemia 58 carotid plaques 58 epithelial ovarian cancer 58 Human papilloma virus 58 germline mutation 58 GBA mutations 58 axillary dissection 58 Endometrial 57 GSTM1 57 homozygotes 57 KIBRA 57 lymphomas leukemias 57 Folate deficiency 57 leukaemias 57 hydroxyvitamin D levels 57 intrauterine infection 57 carotid stenosis 57 latent celiac disease 57 AAT deficiency 57 Opportunistic infections 57 Salmonella Typhi 57 atypical ductal hyperplasia 57 low expressors 57 intestinal metaplasia 57 bladder ovarian 57 BRAF V#E 57 endometrial ovarian 57 Ovary removal 57 toxoplasma 57 obstructive coronary 57 thyroid hormone levels 57 adiponectin levels 57 facial clefts 57 asymptomatic carriers 57 hepatocellular carcinomas 57 faulty BRCA2 gene 57 Human papillomavirus 57 apolipoprotein E 57 KIF6 gene variant 57 prolonged QT interval 57 pre eclamptic 57 diagnostic biomarker 57 ovarian cancers 57 genital lesions 57 adenoma 57 APOE allele 57 CMV infection 57 clinically insignificant 57 colon tumors 57 aneuploidies 57 fetal malformations 57 microvascular disease 57 Human papillomavirus HPV 57 coinfected 57 pre cancerous polyps 57 Li Fraumeni syndrome 57 pancreatic lung 57 ovarian uterine 57 Cholangiocarcinoma 57 bicuspid aortic valves 57 MTHFR gene 57 colorectal adenomas 57 prescribed statins 57 BRAF mutations 57 seminoma 57 basal cell skin 57 benign proliferative breast 57 cause cardiac channelopathies 57 liver metastasis 57 C#Y 57 taxane therapy 57 HLA DQ2 57 abnormal cytology 57 Menopausal hormone therapy 57 HBV infections 57 microsatellite instability 57 virus XMRV 57 metachronous 57 BRAF mutation 57 latent TB infection 57 chromosomal alterations 57 lobular involution 57 APOC3 57 mtDNA mutations 57 colorectal polyp 57 antiphospholipid antibodies 57 pelvic lymphadenectomy 57 poor metabolizers 57 non mutated KRAS 57 colorectal neoplasms 57 GSTP1 57 Acute myeloid leukemia 57 undergo prostate biopsy 57 T. vaginalis 57 Basal cell 57 onset diabetes mellitus 57 familial clustering 57 herpesviruses 57 LRAT 57 rs# [001] 57 recurrent bladder 57 RIP1 57 pT3 57 benign noncancerous 57 diabetes mellitus DM 57 grade serous ovarian 57 smoldering myeloma 57 cisplatin resistant 57 recurrent miscarriages 57 grade cervical dysplasia 57 anal HPV 57 nonmelanoma skin cancer 57 malignant polyps 57 anal lesions 57 vaginal cancers 57 gene variant 57 axillary nodes 57 Leukemias 57 sero positive 57 polycystic ovary syndrome PCOS 57 type 1diabetes 57 cervical HPV 57 spontaneous mutations 57 gastrointestinal stromal tumors GISTs 57 immunodeficient 57 cervical lesions 57 hereditary hemochromatosis 57 glycated hemoglobin levels 56 mosaicism 56 T1DM 56 IPAH 56 biochemical relapse 56 detecting precancerous 56 myeloproliferative neoplasms 56 mutated BRCA 56 deleterious mutation 56 RhD negative 56 recurrent VTE 56 Lung transplantation 56 Trichomonas vaginalis 56 hypovitaminosis D 56 K ras gene 56 Endometrial cancer 56 premalignant lesion 56 neuroendocrine carcinoma 56 micrometastases 56 invasive carcinoma 56 antinuclear antibodies 56 lung adenocarcinomas 56 distal colon cancer 56 narcolepsy cataplexy 56 ductal lobular 56 CYP#D# gene 56 prenatally diagnosed 56 Rh positive 56 TACI mutations 56 urinary bladder cancer 56 autosomal recessive disease 56 BRAF gene 56 squamous cell skin 56 Basal Cell 56 Rh factor 56 cancerous prostates removed 56 cancerdefine 56 Beta thalassemia 56 lupus anticoagulant 56 gene polymorphism 56 glioma rarer 56 dizygotic twins 56 thrombo embolic 56 ovarian lung 56 abnormal methylation 56 tumor histology 56 LRP5 56 VKORC1 56 Clusterin 56 autosomal dominant polycystic kidney 56 pCR 56 M#V mutation 56 leptin deficiency 56 grade cervical intraepithelial 56 metastatic bladder 56 enterovirus infection 56 Gastric cancer 56 LRRK2 mutations 56 dysglycemia 56 gene mutation 56 lymph node removal 56 genital ulcers 56 recessive mutations 56 diabetic kidney 56 nonhereditary 56 HER2 overexpression 56 bloodborne 56 postoperative delirium 56 polyps growths 56 PIGF 56 chromosomal anomaly 56 prostate specific 56 progesterone receptor negative 56 nonischemic 56 carbohydrate intolerance 56 benign breast 56 liver transplant recipients 56 spontaneous preterm delivery 56 node metastases 56 intravenous bisphosphonates 56 metastatic prostate 56 atypia 56 elevated CRP 56 castrate resistant 56 MLL2 56 Erythropoietic therapies may 56 undergone hysterectomy 56 metastatic neuroendocrine tumors 56 pancreatic prostate 56 Leydig cell 56 HBeAg negative 56 GG genotype 56 colorectal gastric 56 cisplatin chemotherapy 56 LungAlert TM 56 Chronic pancreatitis 56 HPV subtypes 56 nonmelanoma 56 chromosomal mutations 56 Chlamydia pneumoniae 56 Cowden syndrome 56 susceptibility gene 56 Rectal cancer 56 spontaneous preterm birth 56 impair fertility 56 chronic hepatitis 56 Polycystic ovary syndrome PCOS 56 spontaneous mutation 56 hyper IgE syndrome 56 resistant hormone refractory 56 irregular menstrual cycles 56 SOD2 gene 56 congenital malformations 56 papillary renal cell carcinoma 56 colorectum 56 hereditary nonpolyposis colorectal cancer 56 asymptomatically 56 penetrance 56 vulvar cancers 56 precancerous tumors 56 HbF 56 enteroviral infection 56 thyroid deficiency 56 ERBB2 56 immunosuppressant therapy 56 Prostate Specific Antigen PSA 56 abnormal mammograms 56 immunocompetent 56 disease NAFLD 56 fetal aneuploidy 56 peritoneal carcinomatosis 56 ALI ARDS 56 cytogenetic abnormalities 56 colorectal polyps 56 Cryptococcus neoformans 56 transthyretin 56 deletion 5q 56 CYP#C# [002] 56 familial hypercholesterolaemia FH 56 leukemias lymphomas 56 chromosomal disorders 56 transfusion syndrome 56 cerebral microbleeds 56 perimenopausal women 56 venous thromboembolic events 56 HPV# 56 Malignant Melanoma 56 androgen receptor gene 56 abnormal Pap 56 Zinc deficiency 56 astrocytomas 56 hepatocellular carcinoma liver 56 Malignant tumors 55 Chlamydia infection 55 PSA nadir 55 Colorectal cancer CRC 55 mammary tumors 55 undergone radical prostatectomy 55 neuroendocrine cancers 55 pituitary adenoma 55 distant metastases 55 mesotheliomas 55 aneuploidy 55 metastatic lung cancer 55 elevated triglycerides 55 GIST tumors 55 singleton pregnancy 55 telomere lengths 55 antigen PSA 55 LRRK2 gene 55 abnormal lipids 55 PSADT 55 human leukocyte antigen 55 chromosome abnormalities 55 neurologic complications 55 cirrhosis liver failure 55 ovarian hormones 55 hypokalemia hypomagnesemia 55 heterotaxy 55 Severe Primary IGFD 55 EBV infection 55 colorectal cancers 55 epithelial tumors 55 chemoresistant 55 gestational diabetes mellitus GDM 55 gene mutations 55 CVD mortality 55 epithelial ovarian 55 IDH mutations 55 AGTR1 55 osteosarcomas 55 autoantibody positive 55 ductal adenocarcinoma 55 colorectal lung 55 gastrointestinal GI cancers 55 Glioblastoma multiforme GBM 55 DQB1 * 55 autosomal dominant inheritance 55 alpha1 antitrypsin AAT deficiency 55 estrogen progestin therapy 55 chromosome translocations 55 CMV infections 55 prophylactic mastectomies 55 urethritis 55 bronchopulmonary dysplasia 55 congenital anomalies 55 Gestational 55 acute myeloid 55 MYH9 55 abnormal lipid levels 55 external genital lesions 55 mutant allele 55 axillary node 55 viremic 55 prostate cancer PCa 55 hepatocellular carcinoma HCC 55 prostate carcinogenesis 55 anaplastic lymphoma kinase 55 EGFR mutation status 55 cervical vulvar 55 localized prostate 55 Genetic mutation 55 thyroid carcinoma 55 Seewaldt 55 preventive mastectomies 55 PCNSL 55 triglyceride concentrations 55 Waldenstrom macroglobulinemia 55 pyelonephritis 55 uterine tumors 55 ABCB1 gene 55 chlamydia sexually transmitted 55 Gliomas 55 ApoE 55 Her2/neu 55 invasive ductal carcinoma 55 aged ≥ 55 BRCA deficient 55 hereditary pancreatitis 55 HER2 amplification 55 methylation markers 55 HLA DRB1 55 Homocysteine levels 55 abnormal Pap smears 55 SLNB 55 pneumococci 55 specific antigen PSA 55 carotid plaque 55 rectal cancers 55 squamous cell cancers 55 squamous cell carcinoma SCC 55 breast carcinomas 55 dominantly inherited 55 systemic scleroderma 55 ovarian carcinoma 55 lymph node metastasis 55 genetic variant 55 thyroid nodules 55 underwent surgical resection 55 TOMM# 55 cervical neoplasia 55 Epidemiologic studies 55 postoperative pulmonary 55 N. gonorrhoeae 55 severe neutropenia 55 HIVAN 55 serum urate levels 55 MCAD deficiency 55 commonly mutated genes 55 deCODE ProstateCancer TM 55 benign polyps 55 troponin T 55 adnexal mass 55 APOE4 gene 55 tibolone 55 premalignant 55 undergo radical prostatectomy 55 HER2 amplified 55 adverse cytogenetics 55 syngeneic 55 cytopathic 55 idiopathic myelofibrosis 55 missense mutations 55 subependymal giant cell 55 mycophenolate 55 pathogenic mutations 55 genital ulcer disease 55 autologous transplants 55 minimally symptomatic 55 clade B 55 tumor subtypes 55 test FOBT 55 hypercholesterolemic patients 55 coronary calcification 55 malignant brain 55 fronto temporal dementia 55 uveal melanoma 55 chronic granulomatous disease 55 stage IIIA 55 oligodendrogliomas 55 genital herpes infections 55 Genetic variations 55 liver decompensation 55 MetS 55 cardiac channelopathies 55 EGFR gene 55 KRAS mutation 55 slow metabolizers 55 chromosomal abnormalities 55 Prostate specific antigen 55 axillary node dissection 55 monogenic 55 JAK2 mutation 55 prophylactic oophorectomy 55 spontaneous miscarriages 55 CHD CVD 55 subclinical hypothyroidism 55 epididymitis 55 primary ovarian insufficiency 55 Chronic lymphocytic leukemia CLL 55 Amniocentesis 55 allele frequencies 55 monoclonal gammopathy 55 KCNE2 55 immunosuppressive medications 55 chromosomal anomalies 55 nonalcoholic steatohepatitis 55 abnormal pap 55 Ribavirin causes 55 recessive genetic 55 invasive lobular carcinoma 55 neurocognitive impairment 55 acute myelogenous leukemia AML 55 familial polyposis 55 endometriosis ovarian cysts 55 faulty BRCA1 gene 55 microalbuminuria 55 densest breasts 55 Invasive Breast Cancer 55 cTnT 55 serum creatinine levels 55 ErbB2 positive 55 locoregional recurrence 55 precancerous condition 55 urothelial cancer 55 e4 allele 55 mutated p# 55 Circulating tumor cells 55 dysplastic lesions 55 nonseminoma 55 Hypertrophic cardiomyopathy 55 prostate ovarian 55 Genetic predisposition 55 estrogen receptor ER 55 de novo mutations 55 underwent prostatectomy 55 abnormal pap smears 55 rs# [004] 55 endometrial breast 55 Viral infections 55 abnormal vaginal bleeding 55 perioperative morbidity 55 drank decaffeinated coffee 55 promoter methylation 55 HIV uninfected 55 Sentinel node biopsy 55 multifactorial disease 55 mutated genes 55 penile cancers 55 advanced epithelial ovarian 55 intraepithelial neoplasia 55 colorectal cancer 55 acute lymphoid leukemia 55 genes CYP#C# 54 nonpregnant women 54 recurrent ischemic stroke 54 WNV infection 54 Hepatocellular Carcinoma HCC 54 selenium intake 54 bacteriuria 54 esophageal cancers 54 undergoing radical prostatectomy 54 prostate walnut 54 Kufs disease 54 LV dysfunction 54 transrectal ultrasound guided 54 euthyroid 54 cervical vaginal 54 thyrotropin 54 NSCLC tumors 54 D dimer 54 hemorrhagic cystitis 54 myeloid leukemia 54 tumors GIST 54 p#INK#a 54 intrahepatic bile duct 54 parathyroid 54 breast cancer recurrences 54 clinically localized prostate 54 underwent radical prostatectomy 54 heterozygotes 54 fallopian tube carcinoma 54 abnormal glucose metabolism 54 transthyretin amyloidosis 54 SE alleles 54 colorectal cancer incidence 54 chromosomal defect 54 Brugada syndrome 54 generalized vitiligo 54 gastric cardia 54 lymphoproliferative disorders 54 Chlamydia trachomatis infection 54 obese postmenopausal 54 Septin9 54 T1c 54 BRCA testing 54 imatinib resistance 54 C. trachomatis 54 ICDs implanted 54 allelic variants 54 androgen deprivation 54 nephrosis 54 tryptase 54 gallstone formation 54 chlamydia infection 54 p# biomarker 54 Radical prostatectomy 54 genomic rearrangement 54 contracting meningococcal disease 54 colorectal tumors 54 premenopausal breast cancer 54 HLA DRB1 * 54 Pelvic inflammatory 54 apoC III 54 hepatocellular cancer 54 breast ovarian 54 pheochromocytomas 54 PARP inhibition 54 unfavorable genotypes 54 lung pancreatic 54 postnatally 54 seroconverted 54 PPCM 54 variant allele 54 GSTT1 54 GBM tumors 54 Wilms tumors 54 Her2 positive 54 elevated ALT 54 placenta praevia 54 venous thrombosis 54 unresectable tumors 54 lobular carcinomas 54 IKZF1 54 postoperative morbidity 54 nonfasting triglyceride levels 54 hydrops 54 somatic mutations 54 adenomatous polyp 54 autoantibody levels 54 B7 H3 54 asymptomatic PAD 54 PCA3 scores 54 haematopoietic 54 elevated hsCRP 54 breast cancer metastasis 54 Ovarian cysts 54 cervical lymph node 54 contralateral breast 54 lymph node involvement 54 orchitis 54 genes BRCA 54 urothelial carcinoma 54 latent tuberculosis infection 54 esophageal squamous cell carcinoma 54 FMR1 gene 54 PTEN mutation 54 hypothalamic amenorrhea 54 genetic syndromes 54 colorectal carcinomas 54 adjuvant radiotherapy 54 uterus womb 54 polycystic ovarian syndrome PCOS 54 lichen planus 54 inherited genetic mutation 54 neural tube defect 54 invasive carcinomas 54 Stomach cancer 54 de aths 54 invasive breast cancer 54 hemorrhagic complications 54 mammographic density 54 SHBG levels 54 elevated fasting glucose 54 curable cancers 54 Gene Mutation 54 Metastases 54 ductal 54 genotyped 54 homozygous 54 gefitinib Iressa 54 meningioma 54 severe congenital neutropenia 54 impaired insulin secretion 54 Genital herpes 54 neuroblastomas 54 SGPT 54 chlamydial 54 PGDH 54 PNET 54 microbleeds 54 Vertebral compression fractures 54 Uterine fibroids 54 latently infected 54 inflammatory rheumatic 54 nondiabetic 54 molecular abnormalities 54 PALB2 gene 54 MALT lymphoma 54 bladder tumors 54 Spinal muscular atrophy 54 LHRH receptor positive 54 nasopharyngeal carcinoma 54 dopaminergic therapy 54 lowest tertile 54 adenocarcinomas 54 KRAS status 54 TNF blocker therapy 54 PTLD 54 CP CPPS 54 CFTR gene 54 heterozygote 54 varicella infection 54 genetic abnormalities 54 fibrate drugs 54 abdominal ultrasounds 54 chorionic villi 54 cervical breast 54 pg ml 54 trophoblastic 54 noninfected 54 Hepatitis B Virus 54 NRTI resistance 54 metastatic brain tumor 54 malignant lymphoma 54 EUS FNA 54 endocrine tumors 54 epigenetic changes 54 abnormal clotting 54 grade squamous intraepithelial 54 thalassemia trait 54 solar keratosis 54 predisposing factor 54 molar pregnancy 54 trastuzumab Herceptin ® 54 plasma triglycerides 54 silent ischemia 54 CYP#D# 54 enteroviral 54 HLA B#